Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
Top Cited Papers
Open Access
- 1 February 2021
- Vol. 70 (2), 433-+
- https://doi.org/10.1136/gutjnl-2020-321666
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyGut, 2020
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysisClinica Chimica Acta; International Journal of Clinical Chemistry, 2020
- COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysisJournal of Medical Virology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Liver injury in COVID-19: management and challengesThe Lancet Gastroenterology & Hepatology, 2020
- Liver Cirrhosis is Independently Associated With 90-Day Mortality in ARDS PatientsShock, 2016
- Comorbidity and survival of Danish cirrhosis patients: A nationwide population-based cohort studyHepatology, 2008